🔎 Trials Near Me

홈 › 과체중 › 메릴랜드

메릴랜드의 과체중 임상 시험

과체중 관련 연구 37개가 메릴랜드 내 여러 지역에서 참여자를 모집하고 있습니다.

메릴랜드의 도시

공식 연구 텍스트(영어)

Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)

  • National Institutes of Health Clinical Center, Bethesda
피험자 모집 중2상건강한 지원자 환영
18세 ~ 60세 · 여성 · 2026. 9. 28. 업데이트됨 · NCT03407079

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • Centennial Medical Group, Columbia
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

  • Ascension Saint Agnes Heart Care, Baltimore
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07595549

Physical and Behavioral Traits of Overweight and Obese Adults

  • National Institutes of Health Clinical Center, Bethesda
피험자 모집 중관찰 연구건강한 지원자 환영
18세 ~ 100세 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT00428987

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

  • Research Site, Beltsville
  • Research Site, Oxon Hill
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07776509

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Johns Hopkins Children's Center, Baltimore
피험자 모집 중3상
6세 ~ 17세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06672549

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

  • Capital Digestive Care - Chevy Chase, Chevy Chase
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Capital Digestive Care - Chevy Chase, Chevy Chase
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  • Centennial Medical Group, Columbia
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07392190

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

  • Flourish Research - Bowie, Bowie
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07369011

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Beltsville
  • Research Site, Lanham
  • Research Site, Oxon Hill
  • 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07784270

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  • MedStar Good Samaritan Hospital, Baltimore
  • MedStar Health Research Institute (MedStar Physician Based Research Network), Hyattsville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07321886

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Ascension Saint Agnes Heart Care, Baltimore
  • MD Medical Research, Oxon Hill
  • Velocity Clinical Research - Rockville, Rockville
피험자 모집 중3상
45세 ~ 99세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Centennial Medical Group, Columbia
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07282600

Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate

  • National Institutes of Health Clinical Center, Bethesda
피험자 모집 중
18세 ~ 65세 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT06044935

Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study

  • National Institutes of Health Clinical Center, Bethesda
피험자 모집 중관찰 연구건강한 지원자 환영
12세 ~ 25세 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT06730113

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  • AURORA-1 Clinical Site, Bowie
  • AURORA-1 Clinical Site, Rockville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Bowie
  • AURORA-2 Clinical Site, Rockville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Centennial Medical Group, Columbia
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • Baltimore VA Medical Center, Baltimore
  • Johns Hopkins University School of Nursing, Baltimore
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Silver Spring
피험자 모집 중3상건강한 지원자 환영
18세 ~ 79세 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT07654374

A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity

  • PAREXEL Intl - EPCU-Baltimore, Baltimore
피험자 모집 중1상
18세 ~ 55세 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07566390

Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder

  • Johns Hopkins University, Baltimore
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06847399

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

  • Kailera Clinical Site, Columbia
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07284875

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

  • Kailera Clinical Site, Annapolis
  • Kailera Clinical Site, Columbia
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07284901

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

  • Barry J. Reiner, MD LLC, Baltimore
피험자 모집 중3상
8세 ~ 18세 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT07253285

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

  • ACCOMPLISH-1 Research Site, Silver Spring
피험자 모집 중3상
18세 ~ 79세 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT07654361

Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change

  • National Institutes of Health Clinical Center, Bethesda
피험자 모집 중
18세 ~ 50세 · 모든 성별 · 2026. 7. 31. 업데이트됨 · NCT06325722

Healthy for Two-Home Visiting (H42-HV): Health Coaching for Pregnant Women

  • Johns Hopkins School of Nursing, Baltimore
피험자 모집 중
18세 이상 · 여성 · 2026. 6. 8. 업데이트됨 · NCT05619705

A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity

  • Parexel International-EPCU Baltimore, Baltimore
피험자 모집 중1/2상건강한 지원자 환영
18세 ~ 60세 · 모든 성별 · 2026. 6. 2. 업데이트됨 · NCT06842186

Night Owl Metabolism

  • Johns Hopkins School of Medicine, Baltimore
피험자 모집 중건강한 지원자 환영
18세 ~ 23세 · 모든 성별 · 2026. 5. 11. 업데이트됨 · NCT06507722

Trial of Food Is Medicine Approaches for Obesity Treatment in Adults With Food Insecurity

  • Johns Hopkins University, Baltimore
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 3. 16. 업데이트됨 · NCT07396805

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

  • Johns Hopkins University, Baltimore
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 1. 16. 업데이트됨 · NCT06273072

Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors

  • Breast Evaluation and Treatment Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore
피험자 모집 중
전 연령 · 여성 · 2025. 12. 23. 업데이트됨 · NCT07032545

Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women

  • Pharmaron CPC, Inc, Baltimore
피험자 모집 중1상건강한 지원자 환영
18세 ~ 55세 · 모든 성별 · 2025. 11. 6. 업데이트됨 · NCT07224399

ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.